European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 4.020
+0.320 (8.65%)
Aug 11, 2026, 12:06 PM CET
EBR:ALEMS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 49.92 | 45.13 | 40.56 | 35.27 | 36.27 |
Other Revenue | 2.88 | 2.78 | 1.96 | 1.79 | 1.75 |
| 52.8 | 47.91 | 42.53 | 37.06 | 38.02 | |
Revenue Growth | 10.21% | 12.67% | 14.76% | -2.53% | 10491.90% |
Cost of Revenue | 33.78 | 30.47 | 27.44 | 23.28 | 24.22 |
Gross Profit | 19.02 | 17.45 | 15.09 | 13.78 | 13.8 |
Selling, General & Admin | 13.65 | 13.12 | 12.13 | 11.48 | 11.28 |
Other Operating Expenses | 0.79 | 0.75 | 0.8 | 1.93 | 0.47 |
Operating Expenses | 16.52 | 16.19 | 15.22 | 15.55 | 13.69 |
Operating Income | 2.5 | 1.26 | -0.14 | -1.77 | 0.12 |
Interest Expense | -0.74 | -0.69 | -0.43 | -0.24 | -0.2 |
Interest & Investment Income | - | - | - | 0.01 | - |
Currency Exchange Gain (Loss) | 0.03 | 0.08 | -0.1 | -0.07 | -0.07 |
Other Non Operating Income (Expenses) | 0.11 | 0.1 | -0.05 | 0 | 0 |
EBT Excluding Unusual Items | 1.91 | 0.75 | -0.71 | -2.07 | -0.15 |
Gain (Loss) on Sale of Assets | - | -0 | - | - | -0.09 |
Other Unusual Items | - | - | - | -3.52 | - |
Pretax Income | 1.91 | 0.75 | -0.71 | -5.58 | -0.24 |
Income Tax Expense | 0.07 | 0.21 | 0 | -0 | -0 |
Earnings From Continuing Operations | 1.84 | 0.55 | -0.71 | -5.58 | -0.24 |
Minority Interest in Earnings | - | - | 0 | 0.01 | - |
Net Income | 1.84 | 0.55 | -0.71 | -5.58 | -0.24 |
Net Income to Common | 1.84 | 0.55 | -0.71 | -5.58 | -0.24 |
Net Income Growth | 237.00% | - | - | - | - |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 0 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 0 |
Shares Change | - | - | - | 6081.03% | 10.08% |
EPS (Basic) | 0.43 | 0.13 | -0.17 | -1.32 | -3.52 |
EPS (Diluted) | 0.43 | 0.13 | -0.18 | -1.32 | -3.52 |
EPS Growth | 237.00% | - | - | - | - |
Free Cash Flow | 2.49 | -1.02 | -4.84 | -0.12 | -1.57 |
Free Cash Flow Per Share | 0.59 | -0.24 | -1.14 | -0.03 | -22.98 |
Gross Margin | 36.02% | 36.41% | 35.48% | 37.18% | 36.31% |
Operating Margin | 4.74% | 2.62% | -0.32% | -4.79% | 0.31% |
Profit Margin | 3.48% | 1.14% | -1.67% | -15.05% | -0.63% |
Free Cash Flow Margin | 4.72% | -2.12% | -11.39% | -0.32% | -4.14% |
EBITDA | 2.93 | 3.3 | 2.06 | 2.32 | 2.05 |
EBITDA Margin | 5.56% | 6.88% | 4.84% | 6.26% | 5.39% |
D&A For EBITDA | 0.43 | 2.04 | 2.2 | 4.09 | 1.93 |
EBIT | 2.5 | 1.26 | -0.14 | -1.77 | 0.12 |
EBIT Margin | 4.74% | 2.62% | -0.32% | -4.79% | 0.31% |
Effective Tax Rate | 3.41% | 27.30% | - | - | - |
Advertising Expenses | 0.23 | 0.24 | 0.23 | 0.23 | - |